Jonathan FassbergDirectorJonathan Fassberg is a visionary entrepreneur who recognized early in his career that small-cap biotechnology companies were underserved in an investor relations capacity. To fill this void, Jonathan founded The Trout Group in 1996 and grew it to become the leading investor relations firm in the life sciences industry. Trout has served over 750 public and private companies both domestically and internationally. In 2017, Trout was acquired by Solebury Communications and the combined firm became known as Solebury Trout. Highlights of Jonathan’s career include guiding Pharmasset, Pharmacyclics and GW Pharma from inception to IPOs to product launches and ultimate acquisitions. Today Jonathan focuses on client service and outreach to investors in order to build stable shareholder bases for his clients. Prior to Trout’s founding, Jonathan was a sell-side analyst at a healthcare-focused investment bank. Before his career on Wall Street, Jonathan spent four years at DuPont Pharma in various sales and marketing positions. Jonathan holds a B.S. in biology and chemistry from The University of North Carolina – Chapel Hill and an MBA in finance from New York University’s Stern School of Business. He also holds Series 7, 24, 79 and 63 securities licenses. Jonathan has been an active member of Young Presidents Organization since joining the Manhattan Chapter in 2007 and is currently serving as Chapter Chair. He also sits on the Board of Directors for the Carolina Center for Jewish Studies at UNC.